Plao, Renato H.
HRN: 24-19-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/16/2023
12/29/2023
IV
500MG
Q6
Tetanus Infection
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous SystemDisseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes